JP2025513774A5 - - Google Patents

Info

Publication number
JP2025513774A5
JP2025513774A5 JP2024558381A JP2024558381A JP2025513774A5 JP 2025513774 A5 JP2025513774 A5 JP 2025513774A5 JP 2024558381 A JP2024558381 A JP 2024558381A JP 2024558381 A JP2024558381 A JP 2024558381A JP 2025513774 A5 JP2025513774 A5 JP 2025513774A5
Authority
JP
Japan
Prior art keywords
xrpd pattern
peaks
pattern obtained
cukα radiation
crystal morphology
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2024558381A
Other languages
English (en)
Japanese (ja)
Other versions
JP2025513774A (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2023/017504 external-priority patent/WO2023196360A1/en
Publication of JP2025513774A publication Critical patent/JP2025513774A/ja
Publication of JP2025513774A5 publication Critical patent/JP2025513774A5/ja
Pending legal-status Critical Current

Links

JP2024558381A 2022-04-05 2023-04-05 Ｍｃｌ－１アンタゴニストの塩形態及び溶媒和物 Pending JP2025513774A (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202263327659P 2022-04-05 2022-04-05
US63/327,659 2022-04-05
PCT/US2023/017504 WO2023196360A1 (en) 2022-04-05 2023-04-05 Salt forms and solvates of mci-1 antagonists

Publications (2)

Publication Number Publication Date
JP2025513774A JP2025513774A (ja) 2025-04-30
JP2025513774A5 true JP2025513774A5 (cg-RX-API-DMAC7.html) 2026-04-10

Family

ID=86386785

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2024558381A Pending JP2025513774A (ja) 2022-04-05 2023-04-05 Ｍｃｌ－１アンタゴニストの塩形態及び溶媒和物

Country Status (9)

Country Link
US (1) US12351588B2 (cg-RX-API-DMAC7.html)
EP (1) EP4504737A1 (cg-RX-API-DMAC7.html)
JP (1) JP2025513774A (cg-RX-API-DMAC7.html)
AU (1) AU2023249146A1 (cg-RX-API-DMAC7.html)
CA (1) CA3254998A1 (cg-RX-API-DMAC7.html)
MX (1) MX2024012192A (cg-RX-API-DMAC7.html)
TW (1) TW202404983A (cg-RX-API-DMAC7.html)
UY (1) UY40217A (cg-RX-API-DMAC7.html)
WO (1) WO2023196360A1 (cg-RX-API-DMAC7.html)

Families Citing this family (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4519271A1 (en) 2022-05-04 2025-03-12 Gilead Sciences, Inc. Salts and polymorphs of certain mcl-1 inhibitors

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JO3474B1 (ar) 2014-08-29 2020-07-05 Amgen Inc مشتقات تيتراهيدرونافثالين التي تثبط بروتين mcl-1

Similar Documents

Publication Publication Date Title
EP3164130B1 (en) Heteroaryl compounds useful as inhibitors of sumo activating enzyme
JP2024001023A5 (cg-RX-API-DMAC7.html)
JP2022049005A5 (cg-RX-API-DMAC7.html)
JP2023554492A5 (cg-RX-API-DMAC7.html)
JP2021535111A5 (cg-RX-API-DMAC7.html)
AU2011236933A1 (en) Cephem compound having catechol group
JP2022507251A5 (cg-RX-API-DMAC7.html)
JP2025513774A5 (cg-RX-API-DMAC7.html)
JP2023519891A5 (cg-RX-API-DMAC7.html)
JP2024534014A5 (cg-RX-API-DMAC7.html)
JP2012516344A5 (cg-RX-API-DMAC7.html)
JP2022511800A5 (cg-RX-API-DMAC7.html)
JP2013538849A5 (cg-RX-API-DMAC7.html)
HK1252449A1 (zh) 突变的异柠檬酸脱氢酶idh1 r132h的抑制剂
JP2022526438A5 (cg-RX-API-DMAC7.html)
KR102612379B1 (ko) 벤조푸란 유도체 자유 염기의 결정 및 제조 방법
JP2023027066A5 (cg-RX-API-DMAC7.html)
ZA200209558B (en) 5-chloro-3-(4-methanesulfonylphenyl)-6'-methyl-[2,3'] bipyridinyl in pure crystalline form and process for synthesis.
JP2024103495A5 (cg-RX-API-DMAC7.html)
JP2022534788A5 (cg-RX-API-DMAC7.html)
JP2024095561A5 (cg-RX-API-DMAC7.html)
JPWO2021033729A5 (cg-RX-API-DMAC7.html)
JP2024539631A5 (cg-RX-API-DMAC7.html)
JP2025511331A5 (cg-RX-API-DMAC7.html)
JP2023524518A5 (cg-RX-API-DMAC7.html)